Efficacy of triamcinolone acetonide dissolving microneedle patch for the treatment of hypertrophic scar and keloid: A randomized, double-blinded, placebo-controlled split-scar study

Division of Dermatology, Department of internal medicine, Faculty of medicine, Thammasat University0 个研究点目标入组 10 人开始时间: 2022年3月18日最近更新: 2024年8月19日

适应症

试验速览

暂无简介。

•1. Healthy male or female participants, aged 18-60.
•2. Participants had hypertrophic scar or keloid more than 2 cm without any previous treatments, more than 6 months of intralesional steroids, or more than 3 months of light & laser treament.
•3. Participants who are willing to join the project after receiving a detailed description of the project and signing a consent form for the study.
•4. Participants can follow the testing method to follow up on treatment results throughout the study period and can report side effects that arise from the study immediately

•1. Participants who had history of treatment with intralesional steroids less than 6 months or light & laser treatment less than 3 months.
•2. Participants who had a history of using systemic corticosteroids (oral, intramuscular, intravenous), chemotherapy, warfarin, heparin, or systemic retinoids
•3. Participants who had active dermatitis or skin infection at the study site
•4. Participants who are pregnant, breastfeeding or planning to become pregnant.
•5. Participants who had a history of liver diseases, renal diseases.
•6. Participants with any type of diabetes mellitus.

发起方

Division of Dermatology, Department of internal medicine, Faculty of medicine, Thammasat University